340 related articles for article (PubMed ID: 8022438)
1. A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second-trimester pregnancy.
Jain JK; Mishell DR
N Engl J Med; 1994 Aug; 331(5):290-3. PubMed ID: 8022438
[TBL] [Abstract][Full Text] [Related]
2. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol.
Peyron R; Aubény E; Targosz V; Silvestre L; Renault M; Elkik F; Leclerc P; Ulmann A; Baulieu EE
N Engl J Med; 1993 May; 328(21):1509-13. PubMed ID: 8479487
[TBL] [Abstract][Full Text] [Related]
3. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol.
el-Refaey H; Rajasekar D; Abdalla M; Calder L; Templeton A
N Engl J Med; 1995 Apr; 332(15):983-7. PubMed ID: 7885426
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate and misoprostol to terminate early pregnancy.
Hausknecht RU
N Engl J Med; 1995 Aug; 333(9):537-40. PubMed ID: 7623901
[TBL] [Abstract][Full Text] [Related]
5. Early pregnancy termination with mifepristone and misoprostol in the United States.
Spitz IM; Bardin CW; Benton L; Robbins A
N Engl J Med; 1998 Apr; 338(18):1241-7. PubMed ID: 9562577
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of intravaginal misoprostol in second-trimester pregnancy termination: a randomized controlled trial.
Dickinson JE; Godfrey M; Evans SF
J Matern Fetal Med; 1998; 7(3):115-9. PubMed ID: 9642607
[TBL] [Abstract][Full Text] [Related]
7. Second trimester pregnancy termination including fetal death: comparison of five different methods.
Yapar EG; Senöz S; Urkütür M; Batioglu S; Gökmen O
Eur J Obstet Gynecol Reprod Biol; 1996 Nov; 69(2):97-102. PubMed ID: 8902440
[TBL] [Abstract][Full Text] [Related]
8. Second-trimester pregnancy termination: comparison of three different methods.
Makhlouf AM; Al-Hussaini TK; Habib DM; Makarem MH
J Obstet Gynaecol; 2003 Jul; 23(4):407-11. PubMed ID: 12881083
[TBL] [Abstract][Full Text] [Related]
9. Termination of second-trimester pregnancy with intracervicovaginal misoprostol.
Srisomboon J; Tongsong T; Pongpisuttinun S
J Med Assoc Thai; 1997 Apr; 80(4):242-6. PubMed ID: 9175393
[TBL] [Abstract][Full Text] [Related]
10. Midtrimester pregnancy termination for fetal malformations. Use of intravaginal prostaglandin E2.
Hagar DL; Valley MT; Rayburn WF; Carey JC
J Reprod Med; 1997 Aug; 42(8):497-500. PubMed ID: 9284011
[TBL] [Abstract][Full Text] [Related]
11. Misoprostol is as effective as gemeprost in termination of second trimester pregnancy when combined with mifepristone: a randomised comparative trial.
Ho PC; Chan YF; Lau W
Contraception; 1996 May; 53(5):281-3. PubMed ID: 8724617
[TBL] [Abstract][Full Text] [Related]
12. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.
Ramsey PS; Savage K; Lincoln T; Owen J
Obstet Gynecol; 2004 Jul; 104(1):138-45. PubMed ID: 15229013
[TBL] [Abstract][Full Text] [Related]
13. Second-trimester termination of pregnancy by extra-amniotic prostaglandin F2alpha or endocervical misoprostol. A comparative study.
Ghorab MN; El Helw BA
Acta Obstet Gynecol Scand; 1998 Apr; 77(4):429-32. PubMed ID: 9598952
[TBL] [Abstract][Full Text] [Related]
14. Vaginal misoprostol vs. concentrated oxytocin plus low-dose prostaglandin E2 for second trimester pregnancy termination.
Owen J; Hauth JC
J Matern Fetal Med; 1999; 8(2):48-50. PubMed ID: 10090490
[TBL] [Abstract][Full Text] [Related]
15. A randomised controlled trial of 6 and 12 hourly administration of vaginal misoprostol for second trimester pregnancy termination.
Herabutya Y; Chanrachakul B; Punyavachira P
BJOG; 2005 Sep; 112(9):1297-301. PubMed ID: 16101611
[TBL] [Abstract][Full Text] [Related]
16. Termination of pregnancy in patients with previous cesarean section.
Mazouni C; Provensal M; Porcu G; Guidicelli B; Heckenroth H; Gamerre M; Bretelle F
Contraception; 2006 Mar; 73(3):244-8. PubMed ID: 16472563
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trial of misoprostol for second-trimester pregnancy termination associated with fetal malformation.
Akoury HA; Hannah ME; Chitayat D; Thomas M; Winsor E; Ferris LE; Einarson TR; Seaward PG; Ryan G; Willan AR; Windrim R
Am J Obstet Gynecol; 2004 Mar; 190(3):755-62. PubMed ID: 15042010
[TBL] [Abstract][Full Text] [Related]
18. Comparison of vaginal and sublingual misoprostol for second trimester abortion: randomized controlled equivalence trial.
von Hertzen H; Piaggio G; Wojdyla D; Nguyen TM; Marions L; Okoev G; Khomassuridze A; Kereszturi A; Mittal S; Nair R; Daver R; Pretnar-Darovec A; Dickson K; Nguyen DH; Nguyen HB; Hoang TD; Peregoudov A;
Hum Reprod; 2009 Jan; 24(1):106-12. PubMed ID: 18794161
[TBL] [Abstract][Full Text] [Related]
19. Second-trimester pregnancy termination with 600-microg vs. 400-microg vaginal misoprostol and systematic curettage postexpulsion: a randomized trial.
Carbonell JL; Torres MA; Reyes R; Ortega L; García-Gallego F; Sánchez C
Contraception; 2008 Jan; 77(1):50-5. PubMed ID: 18082667
[TBL] [Abstract][Full Text] [Related]
20. A viable alternative to surgical vacuum aspiration: repeated doses of intravaginal misoprostol over 9 hours for medical termination of pregnancies up to eight weeks.
Singh K; Fong YF; Dong F
BJOG; 2003 Feb; 110(2):175-80. PubMed ID: 12618162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
